Literature DB >> 29943721

Calcified Neurocysticercosis and Headache in an Endemic Village: A Case-Control Study Nested to a Population-Based Cohort.

Oscar H Del Brutto1, Ana M Robles2, Robertino M Mera3, Aldo F Costa1, Elizabeth Darsan4, Lucía Milla4, Jessica Montes4, Julio Lama5, Victor J Del Brutto6, Mauricio Zambrano7, Mark J Sedler4.   

Abstract

Headache in patients with calcified neurocysticercosis (NCC) is probably common but has been largely overlooked. We aimed to assess the presence, characteristics, and diagnosis of headache across patients with calcified NCC and their matched controls. In this case-control study nested to a population-based cohort, Atahualpa residents aged ≥ 20 years with calcified NCC were identified as case patients and paired 1:1 to age- and gender-matched randomly selected controls. A culturally adapted questionnaire was derived from the EUROLIGHT. Headache diagnosis was established according to the International Classification of Headache Disorders, 3rd edition. Conditional logistic regression models for matched paired data were fitted to assess the independent association between calcified NCC (as the exposure) and headache variables, after adjusting for education, alcohol intake, depression, and epilepsy. The selection process generated 106 case patients and their matched controls. Lifetime headache prevalence (odds ratio [OR]: 4.18; 95% Confidence Interval [CI]: 1.79-9.75; P = 0.001), current headaches (OR: 4.19; 95% CI: 1.92-9.16; P < 0.001), and intense headaches (OR: 9.47; 95% CI: 2.88-31.19; P < 0.001) were more frequent among cases than in controls. In addition, migraine (but not other forms of headache) was more frequent among subjects with calcified NCC (OR: 4.89; 95% CI: 2.36-11.39; P < 0.001). This study shows a robust epidemiological association between headache-particularly migraine-and calcified NCC.

Entities:  

Mesh:

Year:  2018        PMID: 29943721      PMCID: PMC6169166          DOI: 10.4269/ajtmh.18-0310

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  34 in total

1.  Neurocysticercosis: is serology useful in the absence of brain imaging?

Authors:  Hector H Garcia; Silvia Rodriguez; Robert H Gilman; Armando E Gonzalez; Victor C W Tsang
Journal:  Trop Med Int Health       Date:  2012-07-19       Impact factor: 2.622

2.  Calcified neurocysticercosis associates with hippocampal atrophy: a population-based study.

Authors:  Oscar H Del Brutto; Perla Salgado; Julio Lama; Victor J Del Brutto; Xavier Campos; Mauricio Zambrano; Héctor H García
Journal:  Am J Trop Med Hyg       Date:  2014-10-27       Impact factor: 2.345

3.  An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India.

Authors:  Kashi N Prasad; Avantika Verma; Sandeep Srivastava; Rakesh K Gupta; Chandra M Pandey; Vimal K Paliwal
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-07-20       Impact factor: 2.184

Review 4.  Revised diagnostic criteria for neurocysticercosis.

Authors:  O H Del Brutto; T E Nash; A C White; V Rajshekhar; P P Wilkins; G Singh; C M Vasquez; P Salgado; R H Gilman; H H Garcia
Journal:  J Neurol Sci       Date:  2016-11-21       Impact factor: 3.181

5.  Induction of calcitonin gene-related peptide-like immunoreactivity in hippocampal neurons following ischemia: a putative regional modulator of the CNS injury/immune response.

Authors:  K Bulloch; T A Milner; A Prasad; M Hsu; G Buzsaki; B S McEwen
Journal:  Exp Neurol       Date:  1998-04       Impact factor: 5.330

6.  Cysticercotic encephalitis: a severe form in young females.

Authors:  R Rangel; B Torres; O Del Bruto; J Sotelo
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

7.  Headache and cysticercosis in Ecuador, South America.

Authors:  M E Cruz; I Cruz; P M Preux; P Schantz; M Dumas
Journal:  Headache       Date:  1995-02       Impact factor: 5.887

8.  Hydrocephalus and neurocysticercosis: cases illustrative of three distinct mechanisms.

Authors:  Aymeric Amelot; Thierry Faillot
Journal:  J Clin Neurol       Date:  2014-10-06       Impact factor: 3.077

9.  High Prevalence of Asymptomatic Neurocysticercosis in an Endemic Rural Community in Peru.

Authors:  Luz M Moyano; Seth E O'Neal; Viterbo Ayvar; Guillermo Gonzalvez; Ricardo Gamboa; Percy Vilchez; Silvia Rodriguez; Joe Reistetter; Victor C W Tsang; Robert H Gilman; Armando E Gonzalez; Hector H Garcia
Journal:  PLoS Negl Trop Dis       Date:  2016-12-19

10.  Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures.

Authors:  Andres G Lescano; Hector H Garcia; Robert H Gilman; Cesar M Gavidia; Victor C W Tsang; Silvia Rodriguez; Lawrence H Moulton; Manuel V Villaran; Silvia M Montano; Armando E Gonzalez
Journal:  PLoS Negl Trop Dis       Date:  2009-01-27
View more
  4 in total

1.  An Ambispective Cohort Study to Assess Seizure Recurrences in Children with Calcified Parenchymal Neurocysticercosis.

Authors:  Abhijit Modak; Renu Suthar; Indar Kumar Sharawat; Naveen Sankhyan; Jitendra Kumar Sahu; Prahbhjot Malhi; Niranjan Khandelwal
Journal:  Am J Trop Med Hyg       Date:  2019-10       Impact factor: 2.345

Review 2.  A scoping review of burden of disease studies estimating disability-adjusted life years due to Taenia solium.

Authors:  Andrew Larkins; Mieghan Bruce; Carlotta Di Bari; Brecht Devleesschauwer; David M Pigott; Amanda Ash
Journal:  PLoS Negl Trop Dis       Date:  2022-07-06

3.  Estimating the association between being seropositive for cysticercosis and the prevalence of epilepsy and severe chronic headaches in 60 villages of rural Burkina Faso.

Authors:  Ida Sahlu; Hélène Carabin; Rasmané Ganaba; Pierre-Marie Preux; Assana Kone Cissé; Zekiba Tarnagda; Sarah Gabriël; Veronique Dermauw; Pierre Dorny; Cici Bauer; Athanase Millogo
Journal:  PLoS Negl Trop Dis       Date:  2019-01-24

Review 4.  Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world.

Authors:  J Bustos; I Gonzales; H Saavedra; S Handali; H H Garcia
Journal:  J Neurol Sci       Date:  2021-06-17       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.